Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATAD2 | Q6PL18 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | AR | P10275 | 2/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6579528 | 1.00 | ATAD2 (0.33) | ATAD2POLBARAKR1B1CRBN | |
| SCHEMBL9775551 | 0.97 | ATAD2 (0.32) | ATAD2POLBARAKR1B1 | |
| SCHEMBL6235409 | 0.72 | — | — | |
| SCHEMBL8908315 | 0.72 | POLB (0.34) | ATAD2POLBAR | |
| SCHEMBL23962148 | 0.72 | — | — | |
| SCHEMBL4621098 | 0.72 | — | — | |
| SCHEMBL542452 | 0.69 | LMNA (0.36) | — | |
| SCHEMBL1396164 | 0.69 | — | — | |
| SCHEMBL11250686 | 0.69 | POLB (0.32) | POLB | |
| SCHEMBL11702613 | 0.69 | POLB (0.31) | POLBAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 328 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111100587-A | Graphene AB adhesive and preparation method thereof | 苏州桐力光电股份有限公司 | 2020-05-05 | — | — | CN | claimed |
| CN-107841771-A | It is a kind of based on the non-cyanide plating silvering solution composition of complexing ligands system and its application | 厦门大学 | 2018-03-27 | — | — | CN | claimed |
| CN-105540749-B | A kind of rural garbage is percolated liquid tower processing unit | 徐州工程学院 | 2017-12-26 | — | — | CN | claimed |
| US-20020052511-A1 | Process for the preparation of matrix metalloproteinase inhibitors | BAILEY ANNE E (US) | 2002-05-02 | — | — | US | claimed |
| US-20020019539-A1 | Process for the preparation of matrix metalloproteinase inhibitors | ABBOTT LABORATORIES | 2002-02-14 | — | — | US | claimed |
| WO-2001074792-A2 | PROCESS FOR THE PREPARATION OF MATRIX METALLOPROTEINASE INHIBITORS | ABBOTT LABORATORIES (US) | 2001-10-11 | — | — | WO | claimed |
| US-6235928-B1 | ENZYME INHIBITOR MATRIX METALLOPROTEINASE FAMILY, INCLUDING COLLAGENASE, STROMELYSIN, AND GELATINASE, THE COMPOUNDS OR PHARMACEUTICAL COMPOSITIONS | PHARMACIA & UPJOHN COMPANY | 2001-05-22 | — | — | US | claimed |
| EP-0571903-B1 | A method for preparing low free formaldehyde methylol-hydantoins and compositions thereof | LONZA AG (US) | 1996-08-28 | — | — | EP | claimed |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-12354764-B2 | Silver powder, method for producing same, and conductive resin composition | MITSUI MINING & SMELTING CO., LTD. (JP) | 2025-07-08 | — | — | US | disclosed |
| EP-4479138-A1 | INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF | Accent Therapeutics, Inc. (US) | 2024-12-25 | — | — | EP | disclosed |
| US-20240300892-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | AMGEN INC (US) | 2024-09-12 | — | — | US | disclosed |
| WO-2024142789-A1 | GOLD ELECTROPLATING SOLUTION AND METHOD FOR PRODUCING GOLD-ELECTROPLATED COATING | 日本高純度化学株式会社 | 2024-07-04 | — | — | WO | disclosed |
| US-20230360820-A1 | SILVER POWDER, METHOD FOR PRODUCING SAME, AND CONDUCTIVE RESIN COMPOSITION | MITSUI MINING & SMELTING CO., LTD. (JP) | 2023-11-09 | — | — | US | disclosed |
| EP-0144990-B1 | PROCESS FOR PREPARING SILVER HALIDE EMULSION | FUJI PHOTO FILM CO., LTD. (JP) | 1990-04-25 | — | — | EP | disclosed |
| US-4665017-A | GRAIN GROWTH PROMOTOR AND INHIBITOR | FUJI PHOTO FILM CO., LTD. (JP) | 1987-05-12 | — | — | US | disclosed |
| EP-0144990-A2 | Process for preparing silver halide emulsion | FUJI PHOTO FILM CO., LTD. (JP) | 1985-06-19 | — | — | EP | disclosed |
| US-4436910-A | SAPONIFICATION | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1984-03-13 | — | — | US | disclosed |
| US-4282145-A | Process for the preparation of azetidines | GIST-BROCADES N.V. (NL) | 1981-08-04 | — | — | US | disclosed |
| US-4073926-A | BACTERICIDES, FUNGICIDES | GLYCO CHEMICALS, INC. (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240300892-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | MDM2, TP53, CDKN1A | ATAD2 1189/4885POLB 674/4885AR 851/4885 |
| US-20260078091-A1 | Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of Cancer | TP53, HIF1AN, MDM2 | ATAD2 471/4885POLB 350/4885AR 1597/4885 |
| US-20020052511-A1 | Process for the preparation of matrix metalloproteinase inhibitors | MMP9, TIMP3, MMP2 | ATAD2 3089/4885POLB 1444/4885AR 3986/4885 |
| US-20020019539-A1 | Process for the preparation of matrix metalloproteinase inhibitors | MMP9, TIMP3, MMP2 | ATAD2 3089/4885POLB 1444/4885AR 3986/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.